Market closed· · GBp · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Gaming Realms PLC (LSE:GMR, OTCQX:PSDMF, FRA:RNE1) CEO Mark Segal spoke with Proactive's Stephen Gunnion about first-half performance, accelerating content licensing growth, expansion into new regulated markets and plans to increase the pace of game releases. Segal said core content licensing revenue grew 12% in the first half, followed by 23% growth in the subsequent two months, driven by content quality, market expansion, closer partner relationships and strong player engagement. On the UK, Segal noted the remote gaming duty increase began at the start of Q2 and is expected to have a greater
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) says its SLAB gene therapy trial in ageing dogs has hit its primary endpoint. It's now in talks with major animal health companies about a licensing deal. EnergyPathways PLC (AIM:EPP) has appointed Jacobs as engineering and regulatory partner for its MESH energy storage project in the Irish Sea. It's now pushing towards a key Ofgem funding submission. Itaconix PLC (AIM:ITX, OTCQB:ITXXF, FRA:18G0) is targeting a doubling of revenue to $30 million in the medium term. Half-year revenue already jumped 72% thanks to strong detergent demand. G
Gaming Realms PLC (LSE:GMR, OTCQX:PSDMF, FRA:RNE1), the AIM-listed developer and licensor of mobile gaming content, said it was well positioned to build on its momentum and deliver further growth across new and existing markets. The company's UK business proved resilient, with revenues up 3%...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.